Celadon Pharmaceuticals plc (CEL) ORD GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Celadon starts supplying cannabis for two contracts
14 December 2023 11:16
(Sharecast News) - Medical cannabis specialist Celadon Pharmaceuticals has started supplying its pharmaceutical-grade product to two commercial contracts, first announced on 24 May and 5 September, it said...
-
Celadon's new finance chief to join later in January
13 January 2023 13:24
(Sharecast News) - Celadon Pharmaceuticals updated the market on the arrival of its new finance chief on Friday.
-
Celadon confident in approval for its cannabis medicine facility
22 December 2022 14:50
(Sharecast News) - Cannabis-based medicine developer Celadon Pharmaceuticals updated the market on its application for registration of its West Midlands facility with the UK Medicines and Healthcare products...
-
Summerway to buy medicinal cannabis group Vertigrow
28 October 2021 10:10
(Sharecast News) - Summerway Capital has agreed to buy Vertigrow Technology, a medicinal cannabis producer, for £80m to take the business public and expand it.
Company announcements Announcements
-
Product Supplied to First Two Sales Contracts
14 December 2023 07:00
Celadon Pharmaceuticals
-
Fundraise, Update on Future CLN Financing & TVR
12 December 2023 14:00
Celadon Pharmaceuticals
-
New European Sales Contract
16 November 2023 07:00
Celadon Pharmaceuticals
-
Fundraise, CLN Issue, Joint Broker Appointed & TVR
13 October 2023 07:00
Celadon Pharmaceuticals
-
Interim Results
28 September 2023 07:00
Celadon Pharmaceuticals
-
Notice of Results and Investor Presentation
18 September 2023 07:00
Celadon Pharmaceuticals
-
New Sales Contract with UK Pharmaceutical Company
5 September 2023 07:00
Celadon Pharmaceuticals
-
Approval to roll-out chronic pain clinical trial
1 August 2023 07:00
Celadon Pharmaceuticals
-
Result of AGM
29 June 2023 17:30
Celadon Pharmaceuticals
-
Publication of Annual Report and Notice of AGM
5 June 2023 14:46
Celadon Pharmaceuticals
-
Final Results for the year ended 31 December 2022
5 June 2023 07:00
Celadon Pharmaceuticals
-
£7 Million Committed Credit Facility
30 May 2023 07:00
Celadon Pharmaceuticals
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.